Holen Sie sich die Stockscreener-App
3.05
2.24%
-0.07
Handel nachbörslich:
3.11
0.06
+1.97%
Schlusskurs vom Vortag:
$3.12
Offen:
$3.16
24-Stunden-Volumen:
389.51K
Relative Volume:
1.01
Marktkapitalisierung:
$60.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.7625
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-16.89%
1M Leistung:
+8.93%
6M Leistung:
+50.25%
1J Leistung:
+131.06%
1-Tages-Spanne:
$2.95
$3.1758
1-Wochen-Bereich:
$2.95
$3.7499
52-Wochen-Spanne:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.05 | 74.16M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stockPortfolio Update Summary & Real-Time Volume Analysis - newser.com
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.Quarterly Market Review & Real-Time Sentiment Analysis - newser.com
What earnings revisions data tells us about NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical tools2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Technical signs of recovery in NRx Pharmaceuticals Inc.2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Will a bounce in NRx Pharmaceuticals Inc. Equity Warrant offer an exitWeekly Market Report & Safe Entry Point Alerts - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than marketWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soon2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upsidePortfolio Value Report & Expert Approved Momentum Ideas - newser.com
What does recent volatility data suggest for NRx Pharmaceuticals Inc. Equity WarrantGap Down & Weekly Return Optimization Plans - newser.com
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Amarillo Globe-News
Live market analysis of NRx Pharmaceuticals Inc. Equity WarrantTrade Risk Report & Daily Price Action Insights - newser.com
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustai - Corpus Christi Caller-Times
Will NRx Pharmaceuticals Inc. stock gain from government policiesJuly 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Columbia Daily Tribune
Combining machine learning predictions for NRx Pharmaceuticals Inc.2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies - The Globe and Mail
Will NRx Pharmaceuticals Inc. Equity Warrant outperform the marketOptions Play & Scalable Portfolio Growth Ideas - newser.com
NRx Pharmaceuticals Inc. stock trend forecastJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock could outperform in 20252025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Earnings visualization tools for NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
Why NRx Pharmaceuticals Inc. Equity Warrant stock is seen as undervaluedJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Applying Elliott Wave Theory to NRx Pharmaceuticals Inc. Equity WarrantMarket Rally & AI Driven Price Predictions - newser.com
Is NRx Pharmaceuticals Inc. Equity Warrant forming a reversal pattern2025 Dividend Review & Safe Capital Investment Plans - newser.com
NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies - NewMediaWire
Is NRx Pharmaceuticals Inc. Equity Warrant stock bottoming outOptions Play & Expert-Curated Trade Recommendations - newser.com
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):